ALLO Delta Exposure (DEX)

Net delta exposure for Allogene Therapeutics Inc (ALLO) options was $542.99K per 1% move at the Nov 4, 2026 close. It has been positive on 20 of the last 20 trading days. Four weeks earlier, on Oct 7, 2026, it was $501.06K.

Upgrade to unlock Call Wall, Put Wall, and multiple expiration dates.

Upgrade now

Delta Exposure by Strike

Showing results for ALLO, 2026-11-20(m), calls & puts

       

Delta Exposure Stats

Showing results for ALLO, 2026-11-20(m), calls & puts



Net Delta Exposure by Expiration

Showing results for ALLO, 2026-11-20(m), calls & puts. View all expiries

       
Expiration Net DEX Call DEX Put DEX Call Wall Put Wall

ALLO Delta Exposure FAQ

What is delta exposure (DEX)?

Delta exposure estimates the dollar value of shares option dealers hold or owe as a hedge, per 1% move in the underlying.

Is ALLO delta exposure positive or negative?

Allogene Therapeutics net delta exposure was positive on Nov 4, 2026, at $542.99K. It has been positive on 20 of the last 20 trading days.

How has ALLO delta exposure changed recently?

Allogene Therapeutics net delta exposure went from $501.06K on Oct 7, 2026 to $542.99K on Nov 4, 2026. See the ALLO delta exposure history for a longer view.

What is Allogene Therapeutics Inc?

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases.

Give feedback on this chart